首页> 外文期刊>Expert review of vaccines >EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines
【24h】

EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines

机译:EV71疫苗:迈向多价手足口病疫苗的第一步

获取原文
获取原文并翻译 | 示例
           

摘要

Enterovirus A infections are the primary cause of hand, foot and mouth disease in infants and young children. Enterovirus 71 (EV71) and coxsackievirus A16 have emerged as neurotropic viruses responsible for severe neurological complications and a serious public health threat across the Asia-Pacific region. Formalin-inactivated EV71 vaccines have elicited protection against EV71 but not against coxsackievirus A16 infections. The development of a bivalent formalin-inactivated EV71/FI coxsackievirus A16 vaccine should be the next step towards that of multivalent hand, foot and mouth disease vaccines which should ultimately include other prevalent pathogenic coxsackieviruses and echovirus 30. This editorial summarizes the major challenges faced by the development of hand, foot and mouth disease vaccines.
机译:肠病毒A感染是婴幼儿手足口病的主要原因。肠道病毒71(EV71)和柯萨奇病毒A16已作为神经营养性病毒出现,引起整个亚太地区的严重神经系统并发症和严重的公共健康威胁。福尔马林灭活的EV71疫苗已引起针对EV71的保护,但未针对柯萨奇病毒A16感染提供保护。二价福尔马林灭活的EV71 / FI柯萨奇病毒A16疫苗的开发应成为多价手足口病疫苗的下一步,最终应包括其他流行的致病性柯萨奇病毒和回声病毒30。该社论总结了面临的主要挑战开发手足口病疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号